| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
PEPG sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 296.5K | $1.85M | - | |
| CFO | 111.7K | $695.6K | - | |
| VP | 76.3K | $475.2K | - | |
| Other | 65.7K | - | - | |
| Other | 50.1K | $70.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26, 2025 | Donnelly Noel | Chief Financial Officer | Sell | 1,527 | $1.68 | $2,565.36 | -47.7% | -3.9% | +307.8% | |
| Jul 25, 2024 | Mellion Michelle L96 | Chief Medical Officer | Sale+OE | 7,772 | $18.06 | $140,360.37 | -100% | -51.7% | -92.0% | |
| Jul 18, 2024 | Mellion Michelle L96 | Chief Medical Officer | Sale+OE | 12,625 | $18.20 | $229,804.04 | -100% | -45.9% | -91.9% | |
| Jul 16, 2024 | Mellion Michelle L96 | Chief Medical Officer | Sale+OE | 9,189 | $18.02 | $165,578.22 | -100% | -51.4% | -92.9% | |
| Jul 2, 2024 | Mellion Michelle L96 | Chief Medical Officer | Sale+OE | 912 | $18.01 | $16,428.22 | -100% | -47.6% | -92.6% | |
| Jun 24, 2024 | Mellion Michelle L96 | Chief Medical Officer | Sale+OE | 9,260 | $18.19 | $168,427.36 | -100% | -49.7% | -92.2% | |
| Jun 12, 2024 | Mellion Michelle L96 | Chief Medical Officer | Sale+OE | 1,586 | $18.06 | $28,636.68 | -100% | -50.9% | -91.7% | |
| Jun 6, 2024 | Mellion Michelle L96 | SVP, Clinical Development | Sale+OE | 8,656 | $18.08 | $156,460.05 | -100% | -47.5% | -91.3% | |
| May 17, 2024 | Svenstrup Niels | SVP, Chem. Mfg &Controls | Sell | 10,000 | $13.41 | $134,100.00 | -100% | -31.1% | -88.3% | |
| Feb 9, 2024 | Ra Capital Management, L.P.52 | Director, 10% Owner | Buy | 2,557,593 | $10.64 | $27,212,789.52 | +38.6% | -9.0% | -91.5% |